| 000 | 01807cam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 130321s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.14.M.Sc.2012.Mo.C | ||
| 100 | 0 | _aMostafa Sherif Ali | |
| 245 | 1 | 0 |
_aCompararive study between the clinical effect of propranolol vs. prednisolone oral solutions in management of infantile hemangiomas / _cMostafa Sherif Ali ; Supervised Mohamed Magdy Elbarbary , Mamdouh Ahmed Abulhasan , Mohamed Ahmed Abulhasan |
| 246 | 1 | 5 | _aدراسة مقارنة لمعرفة تأثير استخدام عقارى البروبرانولول والبريدنيزولون عن طريق الفم فى علاج الوحمات الدموية لدى الأطفال |
| 260 |
_aCairo : _bMostafa Sherif Ali , _c2012 |
||
| 300 |
_a116P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of General Surgery | ||
| 520 | _aInfantil hemangiomas (IH) comprise the majority of vascular anomalies and are considered the predominant vascular tumor type. Problematic hemangiomas require early and aggressive treatment for ideal functional and cosmetic outcomes. Propranolol is significantly superior to oral; prednisolone in inducing more rapid and greater clinical improvement of infantile hemangioma | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aInfantile hemangioma | |
| 653 | 4 | _aOral propranolol | |
| 653 | 4 | _aProliferative phase | |
| 700 | 0 |
_aMamdouh Ahmed Abulhasan , _eSupervisor |
|
| 700 | 0 |
_aMohamed Ahmed Abulhasan , _eSupervisor |
|
| 700 | 0 |
_aMohamed Magdy Elbarbary , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c42158 _d42158 |
||